Last reviewed · How we verify
NCT06112886
Identification of Important Symptoms and Diagnostic Hypothyroidism Patients Using Machine Learning Algorithms
trial testing There was no intervention in this study in Prediction Hypothyroidism Patients Using Machine Learning Algorithms in 1,296 participants. Completed in 20 September 2023.
12 September 2022
Quick facts
| Lead sponsor | Kerman University of Medical Sciences |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,296 |
| Start date | 12 September 2022 |
| Primary completion | 12 September 2022 |
| Estimated completion | 20 September 2023 |
| Sites | 1 location across Iran |
Drugs / interventions tested
- There was no intervention in this study
Conditions studied
- Prediction Hypothyroidism Patients Using Machine Learning Algorithms — all drugs for Prediction Hypothyroidism Patients Using Machine Learning Algorithms →
- Identification of Important Symptoms of Hypothyroidism — all drugs for Identification of Important Symptoms of Hypothyroidism →
Sponsor
Kerman University of Medical Sciences
Who can join
18 and older, any sex, with Prediction Hypothyroidism Patients Using Machine Learning Algorithms or Identification of Important Symptoms of Hypothyroidism. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Hypothyroidism (HT) is one of the most common endocrine diseases. It is, however, usually challenging for physicians to diagnose due to non-specific symptoms. The usual procedure for diagnosis of HT is a blood test. In recent years, machine learning algorithms have proved to be powerful tools in medicine due to their diagnostic accuracy. In this study, we aim to predict and identify the most important symptoms of HT using machine learning algorithms.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Identification of important symptoms and diagnostic hypothyroidism patients using machine learning algorithms
Rakhshani Rad S, Mohammadi Z, Zadeh M, Mosleh-Shirazi M, et al · · 2024
Verify or expand the search:
- PubMed search for NCT06112886
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Kerman University of Medical Sciences trials
Trials by the same sponsor.
- NCT07311174 — Can Psychodrama Improve Aggressive Behavior and Social Adaptation in Adolescent Boys? · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06112886 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kerman University of Medical Sciences
- Last refreshed: 2 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06112886.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing